Market Research Logo

ChemoCentryx, Inc. - Product Pipeline Review - 2016

ChemoCentryx, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘ChemoCentryx, Inc. - Product Pipeline Review - 2016’, provides an overview of the ChemoCentryx, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by ChemoCentryx, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note:*:Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of ChemoCentryx, Inc.
  • The report provides overview of ChemoCentryx, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses ChemoCentryx, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features ChemoCentryx, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate ChemoCentryx, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for ChemoCentryx, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding ChemoCentryx, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


ChemoCentryx, Inc. Snapshot
ChemoCentryx, Inc. Overview
Key Facts
ChemoCentryx, Inc. - Research and Development Overview
Key Therapeutic Areas
ChemoCentryx, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
ChemoCentryx, Inc. - Pipeline Products Glance
ChemoCentryx, Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
ChemoCentryx, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
ChemoCentryx, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
ChemoCentryx, Inc. - Drug Profiles
CCR-23G - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCR-93G - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-140 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-168 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-354 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-507 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-6239 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-650 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-771 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-872 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-9588 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCX-991 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Antagonize CCR1 for Undisclosed Indication - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Antagonize CXCR6 for Autoimmune, Oncology and Liver Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Target C5aR for Undisclosed Indication - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize CCR and CXCR for Oncology and Autoimmune Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
vercirnon sodium - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ChemoCentryx, Inc. - Pipeline Analysis
ChemoCentryx, Inc. - Pipeline Products by Target
ChemoCentryx, Inc. - Pipeline Products by Route of Administration
ChemoCentryx, Inc. - Pipeline Products by Molecule Type
ChemoCentryx, Inc. - Pipeline Products by Mechanism of Action
ChemoCentryx, Inc. - Dormant Projects
ChemoCentryx, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
CCX-832
vercirnon sodium
ChemoCentryx, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
ChemoCentryx, Inc., Key Facts
ChemoCentryx, Inc. - Pipeline by Indication, 2016
ChemoCentryx, Inc. - Pipeline by Stage of Development, 2016
ChemoCentryx, Inc. - Monotherapy Products in Pipeline, 2016
ChemoCentryx, Inc. - Phase III, 2016
ChemoCentryx, Inc. - Phase II, 2016
ChemoCentryx, Inc. - Phase I, 2016
ChemoCentryx, Inc. - Preclinical, 2016
ChemoCentryx, Inc. - Discovery, 2016
ChemoCentryx, Inc. - Pipeline by Target, 2016
ChemoCentryx, Inc. - Pipeline by Route of Administration, 2016
ChemoCentryx, Inc. - Pipeline by Molecule Type, 2016
ChemoCentryx, Inc. - Pipeline Products by Mechanism of Action, 2016
ChemoCentryx, Inc. - Dormant Developmental Projects,2016
ChemoCentryx, Inc. - Discontinued Pipeline Products, 2016
ChemoCentryx, Inc., Subsidiaries
List of Figures
ChemoCentryx, Inc. - Pipeline by Top 10 Indication, 2016
ChemoCentryx, Inc. - Pipeline by Stage of Development, 2016
ChemoCentryx, Inc. - Monotherapy Products in Pipeline, 2016
ChemoCentryx, Inc. - Pipeline by Top 10 Target, 2016
ChemoCentryx, Inc. - Pipeline by Route of Administration, 2016
ChemoCentryx, Inc. - Pipeline by Molecule Type, 2016
ChemoCentryx, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report